Literature DB >> 25809546

Imputation of class I and II HLA loci using high-density SNPs from ImmunoChip and their associations with Kawasaki disease in family-based study.

S Shrestha1, H W Wiener1, B Aissani1, A Shendre1, J Tang2, M A Portman3.   

Abstract

Kawasaki disease (KD) is the leading cause of acquired heart disease in children in most developed countries including the United States. The etiology of KD is not known; however, epidemiological and immunological data suggest infectious or immune-related factors in the manifestation of the disease. Further, KD has several hereditary features that strongly suggest a genetic component to disease pathogenesis. Human leucocyte antigen (HLA) loci have also been reported to be associated with KD, but results have been inconsistent, in part, because of small study samples and varying linkage disequilibrium (LD) patterns observed across different ethnic groups. To maximize the informativeness of single nucleotide polymorphism (SNP) genotypes in the major histocompatibility (MHC) region, we imputed classical HLA I (A, B, C) and HLA II (DRB1, DQA1, DQB1) alleles using SNP2HLA method from genotypes of 6700 SNPs within the extended MHC region contained in the ImmunoChip among 112 White patients with KD and their biological parents from North America and tested their association with KD susceptibility using the transmission disequilibrium test. Mendelian consistency in the trios suggested high accuracy and reliability of the imputed alleles (class I = 97.5%, class II = 96.6%). While several SNPs in the MHC region were individually associated with KD susceptibility, we report over-transmission of HLA-C*15 (z = +2.19, P = 0.03) and under-transmission of HLA-B*44 (z = -2.49, P = 0.01) alleles from parents to patients with KD. HLA-B*44 has been associated with KD in other smaller studies, and both HLA-C*15 and HLA-B*44 have biological mechanisms that could potentially be involved in KD pathogenesis. Overall, inferring HLA loci within the same ethnic group, using family-based information is a powerful approach. However, studies with larger sample sizes are warranted to evaluate the correlations of the strength and directions between the SNPs in MHC region and the imputed HLA alleles with KD.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25809546      PMCID: PMC4430380          DOI: 10.1111/iji.12190

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  42 in total

1.  Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease.

Authors:  Jane C Burns; Chisato Shimizu; Enrique Gonzalez; Hemant Kulkarni; Sukeshi Patel; Hiroko Shike; Robert S Sundel; Jane W Newburger; Sunil K Ahuja
Journal:  J Infect Dis       Date:  2005-06-08       Impact factor: 5.226

2.  SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap.

Authors:  Andrew D Johnson; Robert E Handsaker; Sara L Pulit; Marcia M Nizzari; Christopher J O'Donnell; Paul I W de Bakker
Journal:  Bioinformatics       Date:  2008-10-30       Impact factor: 6.937

Review 3.  Genetic insights into common pathways and complex relationships among immune-mediated diseases.

Authors:  Miles Parkes; Adrian Cortes; David A van Heel; Matthew A Brown
Journal:  Nat Rev Genet       Date:  2013-08-06       Impact factor: 53.242

4.  The family based association test method: strategies for studying general genotype--phenotype associations.

Authors:  S Horvath; X Xu; N M Laird
Journal:  Eur J Hum Genet       Date:  2001-04       Impact factor: 4.246

5.  HLA antigens in Kawasaki disease.

Authors:  S Kato; M Kimura; K Tsuji; S Kusakawa; T Asai; T Juji; T Kawasaki
Journal:  Pediatrics       Date:  1978-02       Impact factor: 7.124

6.  Functional FCGR2B gene variants influence intravenous immunoglobulin response in patients with Kawasaki disease.

Authors:  Sadeep Shrestha; Howard W Wiener; Aaron K Olson; Jeffrey C Edberg; Neil E Bowles; Hitendra Patel; Michael A Portman
Journal:  J Allergy Clin Immunol       Date:  2011-05-20       Impact factor: 10.793

7.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].

Authors:  T Kawasaki
Journal:  Arerugi       Date:  1967-03

8.  Epidemic and endemic HLA-B and DR associations in mucocutaneous lymph node syndrome.

Authors:  A M Krensky; S Grady; K M Shanley; W Berenberg; E J Yunis
Journal:  Hum Immunol       Date:  1983-02       Impact factor: 2.850

Review 9.  Kawasaki-like syndromes in HIV-infected adults.

Authors:  K Stankovic; P Miailhes; D Bessis; T Ferry; C Broussolle; P Sève
Journal:  J Infect       Date:  2007-10-22       Impact factor: 6.072

Review 10.  Kawasaki-like syndromes and other vasculitic syndromes in HIV-infected patients.

Authors:  Raymond M Johnson; Giorgio Barbarini; Giuseppe Barbaro
Journal:  AIDS       Date:  2003-04       Impact factor: 4.177

View more
  7 in total

1.  A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease.

Authors:  Jae-Jung Kim; Sin Weon Yun; Jeong Jin Yu; Kyung Lim Yoon; Kyung-Yil Lee; Hong-Ryang Kil; Gi Beom Kim; Myung-Ki Han; Min Seob Song; Hyoung Doo Lee; Kee Soo Ha; Sejung Sohn; Todd A Johnson; Atsushi Takahashi; Michiaki Kubo; Tatsuhiko Tsunoda; Kaoru Ito; Yoshihiro Onouchi; Young Mi Hong; Gi Young Jang; Jong-Keuk Lee
Journal:  J Hum Genet       Date:  2017-08-31       Impact factor: 3.172

2.  Whole genome sequencing of an African American family highlights toll like receptor 6 variants in Kawasaki disease susceptibility.

Authors:  Jihoon Kim; Chisato Shimizu; Stephen F Kingsmore; Narayanan Veeraraghavan; Eric Levy; Andre M Ribeiro Dos Santos; Hai Yang; Jay Flatley; Long Truong Hoang; Martin L Hibberd; Adriana H Tremoulet; Olivier Harismendy; Lucila Ohno-Machado; Jane C Burns
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

Review 3.  General and Specific Genetic Polymorphism of Cytokines-Related Gene in AITD.

Authors:  Chen Xiaoheng; Mei Yizhou; He Bei; Li Huilong; Wang Xin; Hu Rui; Li Lu; Ding Zhiguo
Journal:  Mediators Inflamm       Date:  2017-01-04       Impact factor: 4.711

4.  High resolution HLA haplotyping by imputation for a British population bioresource.

Authors:  Matt J Neville; Wanseon Lee; Peter Humburg; Daniel Wong; Martin Barnardo; Fredrik Karpe; Julian C Knight
Journal:  Hum Immunol       Date:  2017-01-19       Impact factor: 2.850

Review 5.  Bioinformatic HLA Studies in the Context of SARS-CoV-2 Pandemic and Review on Association of HLA Alleles with Preexisting Medical Conditions.

Authors:  Mina Mobini Kesheh; Sara Shavandi; Parastoo Hosseini; Rezvan Kakavand-Ghalehnoei; Hossein Keyvani
Journal:  Biomed Res Int       Date:  2021-05-28       Impact factor: 3.411

6.  An HLA-C amino-acid variant in addition to HLA-B*27 confers risk for ankylosing spondylitis in the Korean population.

Authors:  Kwangwoo Kim; So-Young Bang; Seunghun Lee; Hye-Soon Lee; Seung-Cheol Shim; Young Mo Kang; Chang-Hee Suh; Celi Sun; Swapan K Nath; Sang-Cheol Bae; Tae-Hwan Kim
Journal:  Arthritis Res Ther       Date:  2015-11-27       Impact factor: 5.156

7.  FNDC1 Polymorphism (rs3003174 C > T) Increased the Incidence of Coronary Artery Aneurysm in Patients with Kawasaki Disease in a Southern Chinese Population.

Authors:  Kun Lin; Linyuan Zhang; Yishuai Wang; Jinqing Li; Yufen Xu; Di Che; Hanran Mai; Hongyan Yu; Lanyan Fu; Bing Wei; Zhiyong Jiang; Lei Pi; Xiaoqiong Gu
Journal:  J Inflamm Res       Date:  2021-06-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.